NDC11 59417011501
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 59417-0115-01 | 59417-0115 |
| 59417-0115-1 | 59417-0115 |
| 59417-115-01 | 59417-115 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vyvanse | LISDEXAMFETAMINE DIMESYLATE | Takeda Pharmaceuticals America, Inc. | 704e4378-ca83-445c-8b45-3cfa51c1ecad | 2026-04-30 | Boxed warning, Warnings, Adverse reactions | 59417-115-01 59417-115 59417011501 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.